Skip to main content

Zimmer Biomet S.E.T revenue

  • ZBH · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$103.21−1.29%Close 13 Nov 2026

S.E.T revenue at Zimmer Biomet came to $578.3M for the quarter to 30 Sep 2026, up 6.8% from a year earlier.

As Zimmer Biomet reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 4 Nov 2026.

By quarter

$453.3MDec 2023$452.6MMar 2024$469.5MJun 2024$454.2MSep 2024$489.3MDec 2024$470.5MMar 2025$550.6MJun 2025$541.5MSep 2025$587.6MDec 2025$562.2MMar 2026$586.0MJun 2026$578.3MSep 2026
Zimmer Biomet S.E.T revenue, every reported period
Period endingS.E.T revenueChange on a yearFiled
30 Sep 2026$578.3Mup 6.8%4 Nov 2026
30 Jun 2026$586.0Mup 6.4%5 Aug 2026
31 Mar 2026$562.2Mup 19.5%1 May 2026
31 Dec 2025$587.6Mup 20.1%20 Feb 2026
30 Sep 2025$541.5Mup 19.2%5 Nov 2025
30 Jun 2025$550.6Mup 17.3%7 Aug 2025
31 Mar 2025$470.5Mup 4.0%5 May 2025
31 Dec 2024$489.3Mup 7.9%25 Feb 2025
30 Sep 2024$454.2Mup 7.3%30 Oct 2024
30 Jun 2024$469.5Mup 6.1%7 Aug 2024
31 Mar 2024$452.6Mup 4.4%2 May 2024
31 Dec 2023$453.3Mup 6.9%23 Feb 2024
30 Sep 2023$423.2Mup 3.4%7 Nov 2023
30 Jun 2023$442.7Mdown 0.8%1 Aug 2023
31 Mar 2023$433.4Mup 4.0%2 May 2023
31 Dec 2022$424.1Mup 3.3%24 Feb 2023
30 Sep 2022$409.4Mdown 6.4%2 Nov 2022
30 Jun 2022$446.4Mdown 3.4%22 Jun 2022
31 Mar 2022$416.8Mdown 0.2%5 May 2022
31 Dec 2021$410.5M—25 Feb 2022
30 Sep 2021$437.6Mup 4.9%4 Nov 2021
30 Jun 2021$462.1Mup 57.9%3 Aug 2021
31 Mar 2021$417.6M—4 May 2021
30 Sep 2020$417.1M—6 Nov 2020
30 Jun 2020$292.7M—5 Aug 2020

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Zimmer Biomet: Knees revenue · Hips revenue · Technology & Data, Bone Cement and Surgical revenue · financial statements

Every KPI and segment of ZBH, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.